Literature DB >> 16533418

Clinical practice guidelines for chronic obstructive pulmonary disease: a review and comparison of current resources.

David J Pierson1.   

Abstract

The first clinical practice guidelines (CPGs) for the assessment and management of patients with chronic obstructive pulmonary disease (COPD) were published 30 years ago. These and subsequent CPGs issued by professional societies and other groups prior to 2000 were consensus recommendations based on expert opinion and available studies, and they have been criticized for being inconsistent and not explicitly evidence-based. The Global Initiative for Chronic Obstructive Lung Disease (GOLD), a joint project of the National Heart, Lung, and Blood Institute and the World Health Organization, released the first of a new generation of rigorous, evidence-based COPD guidelines in 2001. Since that time several other CPGs, notably those developed jointly by the American Thoracic Society (ATS) and the European Respiratory Society (ERS), and by the British National Collaborating Center for Chronic Conditions and Institute for Clinical Excellence, have also become available. While previous COPD guidelines had different severity-grading systems and differed in their therapy recommendations, the new CPGs are remarkably consistent and have very few areas of clinically relevant discrepancy. All are available free via the Internet, provide for regular revision and updating, and include materials for patients and the public, as well as for health-care providers. Although the GOLD and ATS-ERS guidelines both have international authorship and are intended for worldwide use, implementation of many of their recommendations (such as the requirement for spirometry in diagnosis and staging, an escalating management scheme that includes expensive inhaled medications and pulmonary rehabilitation, and consideration for lung-volume reduction surgery) remains beyond the reach of many patients and health care systems.

Entities:  

Mesh:

Year:  2006        PMID: 16533418

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  16 in total

1.  Pulmonary rehabilitation: overwhelming evidence but lost in translation?

Authors:  Kylie Johnston; Karen Grimmer-Somers
Journal:  Physiother Can       Date:  2010-10-18       Impact factor: 1.037

2.  Effect of therapeutic hyperoxia on maximal oxygen consumption and perioperative risk stratification in chronic obstructive pulmonary disease.

Authors:  Hilary M Womble; Richard M Schwartzstein; Richard P Johnston; David H Roberts
Journal:  Lung       Date:  2012-01-17       Impact factor: 2.584

3.  Health care utilization history, GOLD guidelines, and respiratory medication prescriptions in patients with COPD.

Authors:  Joseph Seaman; Anthony C Leonard; Ralph J Panos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-04-07

4.  What role may symptoms play in the diagnosis of airflow limitation? A study in an elderly population.

Authors:  Astri Medbø; Hasse Melbye
Journal:  Scand J Prim Health Care       Date:  2008       Impact factor: 2.581

5.  The validity of diagnostic support of an asthma/COPD service in primary care.

Authors:  Annelies Lucas; Frank Smeenk; Ivo Smeele; Tim Brouwer; Onno van Schayck
Journal:  Br J Gen Pract       Date:  2007-11       Impact factor: 5.386

6.  [Mass screening guidelines for prostate cancer: Should they be utilized in France?].

Authors:  Maxime Gignon; Alain Braillon; François-Xavier Chaine; Gérard Dubois
Journal:  Can J Public Health       Date:  2007 May-Jun

Review 7.  Nebulization of glutathione and N-Acetylcysteine as an adjuvant therapy for COVID-19 onset.

Authors:  José Fábio Santos Duarte Lana; Anna Vitória Santos Duarte Lana; Quézia Souza Rodrigues; Gabriel Silva Santos; Riya Navani; Annu Navani; Lucas Furtado da Fonseca; Gabriel Ohana Marques Azzini; Thiago Setti; Tomas Mosaner; Claudio Lopes Simplicio; Taís Mazzini Setti
Journal:  Adv Redox Res       Date:  2021-08-08

8.  Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians.

Authors:  Gregory D Salinas; James C Williamson; Ravi Kalhan; Byron Thomashow; Jodi L Scheckermann; John Walsh; Maziar Abdolrasulnia; Jill A Foster
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-02-28

9.  Eight-step method to build the clinical content of an evidence-based care pathway: the case for COPD exacerbation.

Authors:  Cathy Lodewijckx; Marc Decramer; Walter Sermeus; Massimiliano Panella; Svin Deneckere; Kris Vanhaecht
Journal:  Trials       Date:  2012-11-29       Impact factor: 2.279

10.  Primary care COPD patients compared with large pharmaceutically-sponsored COPD studies: an UNLOCK validation study.

Authors:  Annemarije L Kruis; Björn Ställberg; Rupert C M Jones; Ioanna G Tsiligianni; Karin Lisspers; Thys van der Molen; Jan Willem H Kocks; Niels H Chavannes
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.